NCT02018406View on ClinicalTrials.gov

Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 5, 2011

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Neurological DiseasesIschemic StrokeHemorrhagic StrokeCerebral PalsyAtypical Parkinson Disease
Interventions
DRUG

Combination injection of EPO and G-CSF

Subcutaneous EPO(300 U/kg)+G-CSF(10 μg/kg) injection once a day, 5 times a cycle (a week), total 3 cycles for 3 months.

DRUG

Injection of normal saline

Subcutaneous normal saline injection once a day, 5 times a cycle (a week), total 3 cycles for 3 months.

Trial Locations (1)

120-752

RECRUITING

Department of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02018406 - Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury | Biotech Hunter | Biotech Hunter